Insider Transactions in Q4 2024 at Aurinia Pharmaceuticals Inc. (AUPH)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2024
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
500,000
+5.6%
|
$4,500,000
$9.09 P/Share
|
|
Dec 06
2024
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
400,000
+4.8%
|
$3,600,000
$9.01 P/Share
|
|
Dec 05
2024
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
300,000
+3.83%
|
$2,400,000
$8.91 P/Share
|
|
Nov 21
2024
|
Jill Leversage Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,135
+32.63%
|
-
|
|
Nov 21
2024
|
Karen L. Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,135
+32.85%
|
-
|
|
Nov 21
2024
|
Jeffrey Allen Bailey Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,135
+32.25%
|
-
|
|
Nov 21
2024
|
Craig A Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
20,631
+50.0%
|
-
|
|
Nov 21
2024
|
David R.W. Jayne Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,135
+17.68%
|
-
|
|
Nov 11
2024
|
Jeffrey Allen Bailey Director |
SELL
Open market or private sale
|
Direct |
4,557
-25.44%
|
$36,456
$8.43 P/Share
|
|
Nov 11
2024
|
Karen L. Smith Director |
SELL
Open market or private sale
|
Direct |
5,241
-29.26%
|
$41,928
$8.43 P/Share
|
|
Nov 08
2024
|
Jeffrey Allen Bailey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
17,913
+50.0%
|
-
|
|
Nov 08
2024
|
Karen L. Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
17,913
+50.0%
|
-
|